Editorials

Campbell Soup (CPB) reported fiscal 2026 results on September 24, 2026, after a fiscal year ending August 2, 2026. The headline number—a net loss of $403 million for the full year—tells almost nothing about what actually transpired. Strip away the Q4 impairment charges, and what emerges is a workmanlike business generating consistent operating cash, managing a complex portfolio of legacy and acquired brands, and distributing capital to shareholders.

The story is in the quarterly progression.

For the first nine months of fiscal 2026, Campbell generated the following operating results:

• Q1 (ended Nov 2, 2025): Operating income $336M on revenues of $2,677M (12.6% margin)
• Q2 (ended Feb 1, 2026): Operating income $273M on revenues of $2,564M (10.6% margin)
• Q3 (ended May 3, 2026): Operating income $239M on revenues of $2,366M (10.1% margin)

The first three quarters generated combined operating income of $848M on combined revenues of $7,607M, representing a 11.1% operating margin—stable and respectable for a diversified packaged food manufacturer navigating tariffs, commodity inflation, and shifting consumer preferences.

Then came Q4:

• Q4 (ended Aug 2, 2026): Operating income $4M on revenues of $2,137M (0.2% margin)

This was not a normal operating result. The company reported an income tax benefit (not expense) of $21M in Q4—a clear signal of substantial non-tax-deductible charges. The Q4 pretax loss was $79M, implying operating charges of roughly $75M in the quarter—far below the net loss ultimately reported. This points to large goodwill or intangible asset write-downs.

One of the clearest tests of a business's health is not accounting earnings, but cash generated from operations. In fiscal 2026, Campbell's operating cash flow was $1,039M—a robust figure that moved the needle on capital allocation.

This matters for three reasons:

1. It signals underlying business stability. The company is collecting cash from customers faster than it pays suppliers and internal costs, despite headline turmoil.

2. It enabled capital returns. Campbell paid $470M in dividends and repurchased $26M in shares during the year, returning $496M to shareholders while investing $357M in capex (net investing activities). The company is harvesting cash.

3. It suggests the impairment was a one-time revaluation event, not a sign that the core business is deteriorating. A business in genuine operational distress would struggle to generate $1B in operating cash.

Campbell operates two segments:

• Meals & Beverages: $5,381M (55% of total revenue)
• Snacks: $4,255M (45% of total revenue)

Total segment revenue: $9,636M, which aligns with reported revenues of $9,744M. Both segments contributed materially to the business, though total revenue declined 5.0% year-over-year according to key metrics.

This revenue decline reflects several cross-currents: the divestiture of non-core assets (Pop Secret, Emerald nuts, noosa), tariff headwinds, and consumer pullback in certain categories. None of these are insurmountable. The company's brands—Pepperidge Farm, Goldfish, Swanson, Prego, Pace, V8, and the acquired Rao's line—remain formidable anchors in their categories.

Campbell's stock fell sharply following the September 24 filing, declining from roughly $30 per share in late August to around $19 by late September—a 35% haircut in weeks. This move reflects market punishment for:

• The headline net loss of $403M (which becomes $60M per share, diluting EPS to $1.31, down 35% year-over-year)
• Uncertainty about the nature and scale of impairment charges
• Questions about whether management's previous valuations of acquired assets (notably the 2024 Sovos Brands acquisition for $2.9B) were too aggressive

Yet the market's reaction may have over-corrected. Here's why:

At the fiscal year-end, Campbell reported:

• Total Assets: $15.6B
• Total Goodwill: $5.3B
• Intangible Assets (excluding goodwill): $4.2B
• Total Debt: $7.1B (current + long-term)

The balance sheet is top-heavy with intangibles—a consequence of past acquisitions. But this also highlights a critical insight: the $60M Q4 net loss understates the underlying earning power because it's net of depreciation and amortization of $413M for the year. That $413M annual charge represents the accounting cost of historical acquisitions.

Owner's earnings—the cash generation adjusted for maintenance capital—paint a different picture. With $1,039M in operating cash flow, $26M in share buybacks, and $470M in dividends paid, the company is demonstrating genuine cash harvest capacity. Key metrics report an owner earnings per share of $1.53 and a P/Owner Earnings multiple of just 12.7x, suggesting the market may be pricing in distress that isn't evident in cash generation.

A dividend yield of 8.1% on the post-decline stock price is also noteworthy for a business with $1B in operating cash flow. At these yields, the market is essentially betting either that dividends will be cut or that equity value will continue eroding—conclusions that the operating cash flow data does not yet support.

Q4 carried a tax benefit of $21M, against Q1–Q3 tax expense of $145M (total = $124M expense in the income statement).

Given the structure of Campbell's balance sheet, this impairment almost certainly relates to:

1. Goodwill associated with the Sovos Brands acquisition ($2.9B deal closed March 2024), which included the premium Rao's brand and other high-margin specialty lines.
2. Intangible assets tied to prior acquisitions that may have underperformed expectations.

If part of the $5.3B goodwill pool was deemed impaired, the market is now grappling with the idea that some acquisition premiums were unwarranted. But this does not mean the underlying brands are worth zero. Rao's remains a leading premium pasta sauce. Pepperidge Farm remains a category anchor. The operational business that generated $848M in operating income in the first three quarters hasn't evaporated.

The impairment is a write-down of past purchase prices, not a claim that the business is unsalvageable. A value investor must distinguish between the two.

On the Downside:

• Revenue is declining (-5% YoY), driven by divestitures and competitive pressures.
• The company operates in a structurally challenged packaged food space, facing private label competition, e-commerce disruption, and shifting consumer taste toward fresher, simpler foods.
• The Sovos acquisition, made at scale in 2024, has already suffered material impairment, raising questions about acquisition discipline.
• Leverage remains material at $7.1B debt against $1B operating cash flow, leaving limited room for further deterioration.
• Tariff headwinds are expected to intensify in 2026, according to the business description.

On the Upside:

• The underlying core business generated 11% operating margins in the first three quarters, with consistent operating cash generation.
• The company is harvesting capital ($470M dividends + $26M buybacks) while maintaining a $1B operating cash flow stream, suggesting management has room to maneuver.
• Trading at a 12.7x owner earnings multiple and an 8.1% dividend yield reflects deep skepticism that may be overdone if operations stabilize even modestly.
• The portfolio includes genuine brand assets—Pepperidge Farm, Goldfish, Snyder's-of-Hanover, Prego, Pace, and Rao's—that have durable competitive positions in their categories.
• The market has already priced in significant distress; even a modest stabilization could drive substantial re-rating.

The Key Test Ahead:

Fiscal 2027 operating results will determine whether the first-nine-month trend can be restored. If Q1–Q3 FY2027 operating margins revert toward 10–11%, the impairment charge becomes a sideshow and the business deserves a higher multiple. If operating margins compress further, the market's skepticism is justified.

For now, the data suggests a solid core business masked by one-time charges, but one that must prove it can stabilize amid secular headwinds.